Ryan Thomas F Jr - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	7	1	-1	-1	14	12	32	10
P	%wins				43	43	43	86	29	71	52
S	%ret	1	1	13	1	-0	-2	6	19	58	14
S	%wins				62	69	54	42	25	22	46

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/2/22 21:14	3/1/22	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	39	38.76	0	1	219	1	D
3/2/22 21:14	3/1/22	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-396	198.03	0	-2	-58	1	D
11/4/21 17:45	11/2/21	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	165	128.18	0	1	12	12	D
11/4/21 17:45	11/2/21	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.dm	-676	295.87	0	-2	-16	12	D
8/5/21 19:33	8/4/21	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-195	250.50	0	-1	-45	1	D
3/4/21 21:22	3/3/21	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	26	26.12	0	1	216	1	D
3/4/21 21:22	3/3/21	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-205	205.00	0	-1	-41	1	D
11/13/20 16:46	11/11/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	36	38.76	0	1	176	1	D
11/13/20 16:46	11/11/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-175	187.73	0	-1	-39	1	D
8/4/20 19:50	7/31/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	143	67.71	0	2		1	D
8/4/20 19:50	7/31/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-470	151.90	0	-3	-68	1	D
3/18/20 17:10	3/16/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	40	40.42	0	1	108	2	D
3/18/20 17:10	3/16/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-91	91.48	0	-1	-34	2	D
3/5/20 17:53	3/3/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.dm	-617	87.84	0	-7	-78	2	D
3/5/20 17:53	3/4/20	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	200	41.70	0	5		2	D
11/6/18 18:29	11/5/18	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-116	65.75	0	-2	-35	3	D
8/24/18 16:16	8/22/18	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-122	51.44	0	-2	-32	5	D
6/7/18 16:28	6/6/18	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-86	44.31	0	-2	-21	7	D
3/12/18 17:32	3/8/18	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	70	14.95	0	5	117	9	D
3/12/18 17:32	3/8/18	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-170	36.16	0	-5	-35	9	D
3/22/17 16:34	3/20/17	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	13	3.22	8	4	87	9	D	5	39	2	5	16	6	5	0	2	2	5
3/22/17 16:34	3/20/17	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-139	34.83	8	-4	-32	9	D	5	39	2	5	16	6	5	0	2	2	5
9/16/16 13:20	9/14/16	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-88	32.58	8	-3	-22	9	D	72	-8	35	47	10	7	5	1	0	-1	-11	0	6
7/1/16 16:06	6/30/16	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-133	26.60	8	-5	-29	12	D	15	-34	-6	2	14	18	21	17	-3	-1	7	6	13
6/29/16 14:46	6/28/16	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	16	3.22	7	5	41	17	D	10	-40	-14	-7	-2	1	18	5	7	11	12	27	29
6/29/16 14:46	6/28/16	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-246	24.59	7	-10	-37	17	D	10	-40	-14	-7	-2	1	18	5	7	11	12	27	29
5/12/15 08:38	5/8/15	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-744	37.19	14	-20	-50	20	D	313	117	66	65	25	18	31	21	3	8	-1	-4	-31	-31
3/20/15 16:50	3/19/15	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-326	32.62	13	-10	-20	40	D	419	116	71	65	40	30	31	8	-2	-11	3	23	16	-25
11/17/14 10:47	11/13/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	33	3.30	9	10	25	50	D	340	84	28	14	12	-4	-5	-1	0	-2	-13	9	79	12
11/17/14 10:47	11/13/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-238	23.81	9	-10	-17	50	D	340	84	28	14	12	-4	-5	-1	0	-2	-13	9	79	12
7/1/14 08:12	6/27/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	41	4.13	12	10	25	50	D	445	177	80	77	25	12	10	4	5	0	-2	-12	-15	81
7/1/14 08:12	6/27/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-224	22.41	12	-10	-17	50	D	445	177	80	77	25	12	10	4	5	0	-2	-12	-15	81
6/25/14 14:04	6/24/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	50	4.96	11	10	25	50	D	399	179	73	63	21	7	11	6	0	9	5	-10	-5	88
6/25/14 14:04	6/24/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-218	21.78	11	-10	-17	50	D	399	179	73	63	21	7	11	6	0	9	5	-10	-5	88
6/9/14 15:56	6/5/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.d	212	4.72	10	45	847	50	D	404	152	54	45	31	15	10	7	-2	-3	11	-8	8	87
6/9/14 15:56	6/5/14	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.d	-925	20.56	10	-45	-47	50	D	404	152	54	45	31	15	10	7	-2	-3	11	-8	8	87
5/20/13 12:04	5/16/13	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.m	-188	8.97	3	-21	-30	48	M	135	88	67	36	3	-1	-5	0	-2	-4	-11	12	43	106
5/16/13 14:16	5/15/13	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S	-18	9.00	3	-2	-3	62	D	132	85	69	38	12	0	2	0	-1	-8	-15	12	40	102
5/15/13 15:21	5/13/13	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	M.dm	421	5.01	3	84		59	D	133	89	62	35	22	0	0	-5	1	-3	-13	16	40	102
5/15/13 15:21	5/13/13	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	S.dm	-775	9.01	3	-86	-59	59	D	133	89	62	35	22	0	0	-5	1	-3	-13	16	40	102
6/9/06 11:59	11/20/03	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P.a	10	4.96	0	2	New	2	b									-2	-6	-14	5	-6	16
6/9/06 11:56	3/10/05	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P.a	10	1.72	0	6		4	B									-2	-6	-14	5	-6	16
6/9/06 11:56	12/9/05	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P.a	12	2.97	0	4	133	7	b									-2	-6	-14	5	-6	16
12/13/05 13:00	12/9/05	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P	24	2.95	0	8	16	57	M	-38	30	45	-20	-20	-4	1	2	8	9	38	27	-3	-4
3/14/05 10:36	3/10/05	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P	21	1.72	0	12	33	48	M	-51	-44	11	-23	-20	-10	-5	-1	3	0	11	22	125	121
8/16/04 13:55	8/13/04	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P	16	1.59	0	10	40	35	D	-42	-78	-50	-46	-36	5	-6	9	3	10	8	75	30	117
12/3/03 11:42	11/20/03	RGEN	Repligen Corp	DE	Health	BioPrd	Biological Products, (No Diag	Ryan Thomas F Jr	MA	D	P.m	53	4.84	2	11	110	21	M	114	75	-16	-36	0	12	6	7	-3	-9	-19	-43	-48	-55

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y